Primary Site >> Stomach Cancer

Gene >> VTCN1

  • 2010
  • 2011
  • 2014
  • 2015
  • 2016
  • 2018
Ref: [Influence of co-stimulatory molecules B7-H4 expression on the prognosis of patients with gastric cancer treated with cytokine-induced killer cells adoptive immunotherapy].
PMID: 20499308
Ref: Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
PMID: 20725832
Ref: Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis.
PMID: 20872810
Ref: T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
PMID: 21717068
Ref: Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
PMID: 21748517
Ref: Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer.
PMID: 24031123
Ref: Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
PMID: 24947047
Ref: Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.
PMID: 25260881
Ref: Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
PMID: 24804867
Ref: B7-H4 is Predictive of Poor Prognosis in Patients with Gastric Cancer.
PMID: 27820598
Ref: Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
PMID: 29436630